# OnCo record oncomine-dx-target-test (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/oncomine-dx-target-test/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "oncomine-dx-target-test" ;
  schema:name "Oncomine Dx Target Test"@en ;
  schema:description "The first FDA-approved gene panel that could match one biopsy to several different lung cancer drugs at once."@en ;
  schema:url <https://onco.cc/drugs/oncomine-dx-target-test/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P160045>, <https://www.thermofisher.com/uk/en/home/clinical/diagnostic-testing/condition-disease-diagnostics/oncology-diagnostics/oncomine-dx-target-test.html> ;
  onco:status "approved" ;
  onco:tag "test" ;
  onco:modality "Tissue NGS companion diagnostic test (multi-gene panel)" ;
  schema:alternateName "Oncomine Dx Target Test" ;
  onco:approval "US 2017: Companion diagnostic for BRAF, ROS1 and EGFR-directed therapies in NSCLC", "Japan 2019: Multi-gene companion diagnostic system for NSCLC", "US 2020: RET fusion companion claim (pralsetinib)", "US 2021: IDH1 companion claim in cholangiocarcinoma (ivosidenib)" ;
  onco:cancers <https://onco.cc/cancers/nsclc/>, <https://onco.cc/cancers/cholangiocarcinoma/> ;
  onco:technologies <https://onco.cc/technologies/companion-diagnostic/>, <https://onco.cc/technologies/cgp/> ;
  onco:targets <https://onco.cc/targets/egfr/>, <https://onco.cc/targets/braf/>, <https://onco.cc/targets/ros1/>, <https://onco.cc/targets/ret/>, <https://onco.cc/targets/idh/> ;
  onco:drugs <https://onco.cc/drugs/pralsetinib/>, <https://onco.cc/drugs/ivosidenib/> ;
  onco:companies <https://onco.cc/companies/thermo-fisher/> ;
  onco:terms <https://onco.cc/terms/ngs/>, <https://onco.cc/terms/companion-diagnostic-term/> .